Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004179
Status:
COMPLETED
Last Update Posted:
2021-02-15
First Post:
2000-01-21
Brief Title:
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkins Lymphoma
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Organization Data
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Class:
NETWORK
Study ID:
EORTC-20981
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Nordic Lymphoma Group | NETWORK |
| Lymphoma Trials Office | OTHER |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | OTHER |
| Australasian Leukaemia and Lymphoma Group | OTHER |
| NCIC Clinical Trials Group | NETWORK |